The role of azithromycin in patients with cystic fibrosis

Paediatric Respiratory Reviews
Abdullah A Yousef, Adam Jaffe

Abstract

Interest in azithromycin in the management of patients with cystic fibrosis has grown over the last decade. Uniquely this drug has both antibacterial and immune modulating effects which appear to be the reason for its clinical benefit as proven in several well designed clinical studies. In this review we discuss the proposed mechanisms of action of azithromycin and review the evidence for its clinical effectiveness and safety in cystic fibrosis.

References

Jun 1, 1992·Antimicrobial Agents and Chemotherapy·Y HirakataK Yamaguchi
Jan 1, 1991·Respiration; International Review of Thoracic Diseases·H NagaiA Kurashima
Oct 1, 1989·The Journal of Antimicrobial Chemotherapy·M T LabroC Babin-Chevaye
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·H A Kirst, G D Sides
Apr 1, 1995·American Journal of Respiratory and Critical Care Medicine·T Z KhanD W Riches
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·K AoshibaK Konno
Jan 1, 1993·The Journal of Pediatrics·S C FitzSimmons
Apr 1, 1993·Respiratory Medicine·J TredanielA Hirsch
Dec 29, 1995·The American Journal of Medicine·H Kobayashi
Oct 24, 1997·International Archives of Allergy and Immunology·T MitsuyamaN Hara
Jan 7, 2000·Biochemical and Biophysical Research Communications·M DesakiK Ito
May 17, 2001·Antimicrobial Agents and Chemotherapy·K TatedaC Van Delden
Jun 5, 2001·Pediatric Pulmonology·A Jaffé, A Bush
Sep 5, 2002·European Journal of Pharmacology·Ognjen CulićMichael J Parnham
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Lisa SaimanUNKNOWN Macrolide Study Group
Feb 28, 2004·American Journal of Respiratory Cell and Molecular Biology·Markus O HenkeBruce K Rubin
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Omar M PirzadaMark L Everard
Mar 9, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Christine Rønne HansenNiels Høiby
Jul 26, 2005·American Journal of Respiratory and Critical Care Medicine·Lisa SaimanUNKNOWN Macrolide Study Group
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Yusuf NalcaSusanne Häussler
Jan 2, 2007·The Pediatric Infectious Disease Journal·Gerdien A Tramper-StrandersCornelis K van der Ent
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Jun 1, 2007·The European Respiratory Journal·J McCormackS Bowler
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Mette E SkindersoeMichael Givskov
Aug 15, 2008·Respiratory Medicine·Gratiana SteinkampStefan Zielen
Oct 14, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·C R HansenH K Johansen

❮ Previous
Next ❯

Citations

May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julien M BuyckFrançoise Van Bambeke
Jul 11, 2012·Mediators of Inflammation·Helen C SteelCharles Feldman
May 4, 2011·Antimicrobial Agents and Chemotherapy·Isabel Pérez-Martínez, Dieter Haas
Feb 1, 2012·Pulmonary Medicine·Bruna de Campos Guimarães E Figueiredo, Cássio da Cunha Ibiapina
Nov 23, 2011·European Journal of Clinical Pharmacology·P ZarogoulidisK Zarogoulidis
Jun 12, 2012·Pediatric Pulmonology·Lisa SaimanUNKNOWN AZ0004 Macrolide Study Team
Nov 5, 2011·Journal of Periodontal Research·R HirschM N Laohachai
Jan 15, 2014·British Journal of Pharmacology·V BalloyL Guillot
May 25, 2015·Revue des maladies respiratoires·M AbelyM Fayon
Nov 10, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gerd DöringUNKNOWN Consensus Study Group
Jul 22, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Geraint B RogersGerd Döring
Feb 18, 2015·The American Journal of Pathology·Florence SonnevilleOlivier Tabary
Jan 12, 2011·Antimicrobial Agents and Chemotherapy·Vinciane Saint-CriqOlivier Tabary
Sep 20, 2017·Antimicrobial Agents and Chemotherapy·Martina KoevaDiane Joseph-McCarthy
Oct 12, 2019·Annals of the American Thoracic Society·Angélique DenisMuriel Rabilloud
Apr 24, 2019·Journal of Bacteriology·Emily A Williams McMackinTimothy L Yahr
Feb 19, 2011·American Journal of Respiratory and Critical Care Medicine·Malena Cohen-CymberknohEitan Kerem
Nov 15, 2012·Clinical Pharmacology and Therapeutics·S S AntunovicD Vujovic
Jul 8, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Li-Chao FanJin-Fu Xu
Nov 15, 2011·ACS Chemical Biology·Julian Davies, Katherine S Ryan
Sep 9, 2020·ACS Infectious Diseases·Maya A FarhaEric D Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.